Axa’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Sell |
162,745
-89,072
| -35% | -$848K | ﹤0.01% | 812 |
|
|
2025
Q1 | $2.63M | Buy |
251,817
+63,166
| +33% | +$661K | 0.01% | 684 |
|
|
2024
Q4 | $4.44M | Sell |
188,651
-300
| -0.2% | -$7.07K | 0.01% | 570 |
|
|
2024
Q3 | $6.79M | Sell |
188,951
-21,198
| -10% | -$761K | 0.02% | 472 |
|
|
2024
Q2 | $7.42M | Sell |
210,149
-68,417
| -25% | -$2.41M | 0.02% | 450 |
|
|
2024
Q1 | $7.91M | Sell |
278,566
-271,758
| -49% | -$7.72M | 0.02% | 452 |
|
|
2023
Q4 | $7.32M | Buy |
550,324
+74,298
| +16% | +$988K | 0.02% | 465 |
|
|
2023
Q3 | $4.27M | Sell |
476,026
-1,704
| -0.4% | -$15.3K | 0.02% | 565 |
|
|
2023
Q2 | $5.37M | Buy |
477,730
+53,617
| +13% | +$603K | 0.02% | 539 |
|
|
2023
Q1 | $4.89M | Buy |
424,113
+55,328
| +15% | +$637K | 0.02% | 570 |
|
|
2022
Q4 | $4.27M | Buy |
+368,785
| New | +$4.27M | 0.02% | 643 |
|